top of page

News & Updates

Filter by:

Lucence Announces Commercial Availability of Tissue500™ for Comprehensive Targeted Therapy Matching

News & Updates

14 Sept 2021

Lucence Announces Commercial Availability of Tissue500™ for Comprehensive Targeted Therapy Matching

Read More
Lucence Announces Commercial Availability of Tissue500™ for Comprehensive Targeted Therapy Matching
Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board

News & Updates

2 Jun 2021

Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board

Read More
Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board
Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer

News & Updates

11 May 2021

Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer

Read More
Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer
Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening

News & Updates

24 Mar 2021

Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening

Read More
Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening
Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy Tests

News & Updates

10 Dec 2020

Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy Tests

Read More
Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy Tests
Lucence Shares Data at ASCO20 Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung Cancer

News & Updates

26 May 2020

Lucence Shares Data at ASCO20 Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung Cancer

Read More
Lucence Shares Data at ASCO20 Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung Cancer
Lucence Presents Data Demonstrating Potential of AmpliMARK™ Powered Sequencing to Detect Genomic Alterations at High Sensitivity in Blood Cancers

News & Updates

14 Jan 2020

Lucence Presents Data Demonstrating Potential of AmpliMARK™ Powered Sequencing to Detect Genomic Alterations at High Sensitivity in Blood Cancers

Read More
Lucence Presents Data Demonstrating Potential of AmpliMARK™ Powered Sequencing to Detect Genomic Alterations at High Sensitivity in Blood Cancers
Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid Biopsy for Early Detection of Multiple Cancers

News & Updates

20 Nov 2019

Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid Biopsy for Early Detection of Multiple Cancers

Read More
Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid Biopsy for Early Detection of Multiple Cancers

1

/

4

bottom of page